| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/24/2005 | CN1658904A Combinations comprising epothilones and pharmaceutical uses thereof |
| 08/24/2005 | CN1658901A Methods for treating TWEAK-related conditions |
| 08/24/2005 | CN1657619A Recombination human erythropoietin gene suitable for pronucleus expression system and its expression carrier |
| 08/24/2005 | CN1657618A Hepatic correlative oncogene inhibitory and use |
| 08/24/2005 | CN1657541A Process for preparating specificity complex IgY of anti coxsackie virus myocarditis and its compound preparation |
| 08/24/2005 | CN1216076C Monoclonal antibody resisting human small cell lung carcinoma and its application |
| 08/23/2005 | US6933422 Nav2 channel gene-deficient mice |
| 08/23/2005 | US6933368 Increasing antibody affinity by altering glycosylation of immunoglobulin variable region |
| 08/23/2005 | US6933366 Specificity exchangers that redirect antibodies to bacterial adhesion receptors |
| 08/23/2005 | US6933276 Methods of treating peripheral neuropathies using neurotrophin-3 |
| 08/23/2005 | US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin |
| 08/23/2005 | US6933148 Cell separation compositions and methods |
| 08/23/2005 | US6933147 Human cyclic nucleotide-gated channel polypeptide |
| 08/23/2005 | US6933135 monoclonal antibody having intracellular domain of leukocyte antigen related molecule and domain of CD45; for prophylaxis and diagnosis of syndrome X, arteriosclerosis, and cardiovascular disorders based on insulin resistance |
| 08/23/2005 | US6933125 Human c-Maf compositions and methods of use thereof |
| 08/23/2005 | US6933116 Nucleic acid ligand binding site identification |
| 08/23/2005 | US6933108 Treating viral disease in mammals; administer viricide to mammal, monitor activity of virus, reduced viral activity indicates effective viricide |
| 08/23/2005 | US6932969 Ig fractions having immunomodulatory activity |
| 08/23/2005 | US6932968 An anti-idiotype antibody against the binding region of an antibody directed against an EPO peptide, wherein said antibody neutralizes the bioactivity of EPO; diagnostic aids for the detection of EPO or of anti-EPO antibodies |
| 08/23/2005 | US6932967 Human medical treatment by aerosol inhalation of immunoglobulin A |
| 08/23/2005 | CA2368734C Method for preparing monoclonal antibody |
| 08/23/2005 | CA2142300C Methods for detecting alzheimer's disease |
| 08/23/2005 | CA2094276C Antibodies against the urokinase receptor and their use |
| 08/18/2005 | WO2005076013A2 Process for screening glycoform-specific antibodies |
| 08/18/2005 | WO2005076012A2 Novel splice variants and methods of use thereof |
| 08/18/2005 | WO2005075647A1 Humanized antibody |
| 08/18/2005 | WO2005075515A2 Immunoglobulins and method for their modification |
| 08/18/2005 | WO2005075514A2 Method for producing antibodies |
| 08/18/2005 | WO2005075513A1 Dj-1 derivative having acidified cysteine residue |
| 08/18/2005 | WO2005075504A1 IDENTIFICATION OF NOVEL IgE EPITOPES |
| 08/18/2005 | WO2005075003A1 Implantable medical devices for treating or preventing restenosis |
| 08/18/2005 | WO2005074985A2 Methods of modulating cd200 and cd200r |
| 08/18/2005 | WO2005074984A1 Hmgb1 protein inhibitors for the regulation of smooth muscle cells and endothelial cells profileration |
| 08/18/2005 | WO2005074972A2 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists |
| 08/18/2005 | WO2005074645A2 Methods and compositions for modulating angiogenesis |
| 08/18/2005 | WO2005074633A2 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 08/18/2005 | WO2005074604A2 METHODS OF DETECTING Lp-PLA2 ACTIVITY |
| 08/18/2005 | WO2005061545A3 Nogoa antibodies for the treatment of alzheimer disease |
| 08/18/2005 | WO2005061544A3 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 08/18/2005 | WO2005058952A3 Ztnf13, a tumor necrosis factor |
| 08/18/2005 | WO2005054295A8 Therapeutic and diagnostic anti-hsp 70 antibodies |
| 08/18/2005 | WO2005052122A3 METHODS FOR CONTROLLING PATHOLOGICAL ANGIOGENESIS BY INHIBITION OF α6β4 INTEGRIN |
| 08/18/2005 | WO2005050200A9 Screening assays and methods of tumor treatment |
| 08/18/2005 | WO2005033133A3 Polynucleotides encoding erbb-2 polypeptides and kits and methods using same |
| 08/18/2005 | WO2005027846A3 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 08/18/2005 | WO2005023980A3 Use of complement protein c3 and its derivatives in enhancing mammalian embryo development |
| 08/18/2005 | WO2005023865A3 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene |
| 08/18/2005 | WO2005020924A3 A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method |
| 08/18/2005 | WO2005013899A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/18/2005 | WO2005010049A3 Tgf-beta1 ligands |
| 08/18/2005 | WO2005010044A3 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 08/18/2005 | WO2005001096A8 Vaccines against sars |
| 08/18/2005 | WO2004100898A3 Therapeutic use of anti-cs1 antibodies |
| 08/18/2005 | WO2004094607A3 Methods of therapy and diagnosis using targeting of cells that express a human transporter-like protein |
| 08/18/2005 | WO2004084821A3 Hemipteran glutamate decarboxylase |
| 08/18/2005 | WO2004058949A3 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
| 08/18/2005 | WO2004045519A3 Induction of apoptosis by hiv-1 infected monocytic cells |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050183148 Lymphocyte surface receptor that binds caml and methods of use thereof |
| 08/18/2005 | US20050182249 Nucleotide sequences coding tumor suppressor protein for use in diagnosis, prevention and treatment of cancer; antitumor agents |
| 08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 08/18/2005 | US20050182003 Drugs to be used in gene therapy for recessively transmitted genetic disease |
| 08/18/2005 | US20050181982 Crystal structures of anti-factor IX Fab fragments and methods of use for peptidomimetic design |
| 08/18/2005 | US20050181979 Vascular endothelial growth factor-2 |
| 08/18/2005 | US20050181501 Anti-TECK antibodies and methods of use therefor |
| 08/18/2005 | US20050181483 Method for producing monoclonal antibodies |
| 08/18/2005 | US20050181479 Expression vector comprising nucleotide sequences coding single sequence, multimeric immunoglobulin |
| 08/18/2005 | US20050181478 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/18/2005 | US20050181476 Novel splice variant of MyD88 and uses thereof |
| 08/18/2005 | US20050181475 Immunoglobulin which comprises at least two different epitopes of a tumor-associated antigen for use as diagnostic and therapeutic tool in detection, treatment and prevention of cell proliferative disorders; immunotherapy |
| 08/18/2005 | US20050181462 Mutant androgen receptor, cancer cells expressing the same, a method of producing them and use thereof |
| 08/18/2005 | US20050181460 Antibody specific to central nervous system tau protein |
| 08/18/2005 | US20050181452 Bioassay for functional characterization of G protein coupled and de-orphanization of receptors; high throughput screening; pharmacological profiling; drug screening and design |
| 08/18/2005 | US20050181450 Novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein and an IP3 indicator |
| 08/18/2005 | US20050181448 Biological products |
| 08/18/2005 | US20050181446 Protein variants having modified immunogenicity |
| 08/18/2005 | US20050181443 Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same |
| 08/18/2005 | US20050181439 Streptococcus pneumoniae antigens and vaccines |
| 08/18/2005 | US20050181422 Process for high throughput screening of CpG-based immuno-agonist/antagonist |
| 08/18/2005 | US20050181419 For detection of Mycobacterium tuberculosis infection |
| 08/18/2005 | US20050181418 Using nuclear protein (AM-1) as screening tool in diagnosing metastatic cancer |
| 08/18/2005 | US20050181414 Peptides associated with serine protease active site for use in identification of modulators for treatment of cell proliferative disorders |
| 08/18/2005 | US20050181413 Ovarian specific nucleic acid (OSNA) for use as diagnostic and prognostic tools in treatment and prevention of urogenital cancers; genetic vaccines |
| 08/18/2005 | US20050181391 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 08/18/2005 | US20050181375 Using presence of metastatic lung cancer-associated transcripts as diagnostic tool in diagnosis, prognosis and characterization of cell proliferative disorders |
| 08/18/2005 | US20050181372 Interleukin 17 receptor-like protein |
| 08/18/2005 | US20050181368 Protein for use in hypoxia related conditions |
| 08/18/2005 | US20050181355 Compositions and methods for the modulation of viral maturation |
| 08/18/2005 | US20050180986 Collagen-binding proteins from Enterococcal bacteria |
| 08/18/2005 | US20050180983 Antibody vaccine conjugates and uses therefor |
| 08/18/2005 | US20050180981 Human checkpoint kinase, hCDS1, compositions and methods |
| 08/18/2005 | US20050180980 Novel antibody recognizing a small subset of human hematopoietic cells |
| 08/18/2005 | US20050180979 Treating tumorous disease in human by administering human immunoglobulin specifically binding to the human epithelial cell adhesion molecule(EpCAM) antigen, said immunoglobulin exhibiting a serum half-life of at least 15 days, the method comprising administering immunoglobulin once every week |
| 08/18/2005 | US20050180978 Isolated monoclonal antibody mAb PAB-1, deposited at ATCC on 24 Jan. 2002 and accorded accession PTA-4005, which binds to a surface antigen on nematode L3; use in preventing or treating animal nematode infections |
| 08/18/2005 | US20050180977 Antibodies that bind to ET2, such as immunoglobulins that inhibit ET2 with high affinity and selectivity; can be used to treat angiogenesis-associated disorders. |
| 08/18/2005 | US20050180976 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases |
| 08/18/2005 | US20050180975 Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma |
| 08/18/2005 | US20050180974 directly delivering interleukin 10 signal transduction modifying agent to cerebrospinal fluid and/or brain tissue |
| 08/18/2005 | US20050180972 high potency and/or are capable of promoting accumulation of the anti-CD20 ADC into CD20-expressing cells; pharmaceutical compositions and kits |
| 08/18/2005 | US20050180970 Use of molecularly engineered binding domain-immunoglobulin fusion proteins, including single chain Fv-immunoglobulin fusion protein useful for treating malignant conditions and B-cell disorders, such as disease caused by autoantibody production |